Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition

benzinga.com/general/biotech/25/05/45561443/sanofi-boosts-alzheimers-pipeline-with-vigil-neuroscience-acquisition

Vigil Neuroscience, Inc. (NASDAQ:VIGL) on Wednesday disclosed that it entered a deal to be acquired by Sanofi (NASDAQ:SNY) for an equity value of approximately $470 million (on a fully diluted basis).
Per the terms, Sanofi will pay $8.00 per share in cash to acquire Vigil. In addition,…

This story appeared on benzinga.com, 2025-05-22 11:21:48.
The Entire Business World on a Single Page. Free to Use →